今开:0.0 | 昨收:11.83 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:6.21202587E8 |
chuminhua2023-01-31 12:19
1月30日,FDA 宣布批准 Stemline Therapeutics $Stemline医疗(STML)$ 的 口服选择性雌激素受体降解剂(SERD)Orserdu(elacestrant)用于患有 ER+/HER2-、ESR1 突变的晚期或转移性乳腺癌且在至少一种内分泌治疗后疾病进展的绝经后女性或成年男性。 该机构去年给与该申请优先审评。网页链接查看全文
牛唐2020-01-16 21:55
研发类药企商业化任重道远,成功概率小,多半是好药在手,难以销售$Portola制药(PTLA)$ $Stemline医疗(STML)$ 就是这个道理。$欢聚时代(YY)$查看全文
$STEMLINE THERAPEUTICS INC(STML)$ 美东时间 2016-01-14 14:30 Stemline Therapeutics Inc at JPMorgan Healthcare Conference 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 美东时间 2016-01-14 14:30 Stemline Therapeutics Inc at JPMorgan Healthcare Conference 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 8-K - Current report Filed: 2015-12-10 AccNo: 0001104659-15-083954 Size: 123 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 美东时间 2015-12-09 14:10 Stemline Therapeutics Inc at Oppenheimer Healthcare Conference 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 内部交易: 2015-11-30,CEO,Bergstein Ivan ,卖出,12235普通股, $8.20
$STEMLINE THERAPEUTICS INC(STML)$ 8-K - Current report Filed: 2015-11-06 AccNo: 0001104659-15-076445 Size: 151 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-11-06 AccNo: 0001104659-15-076519 Size: 5 MB 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 8-K - Current report Filed: 2015-10-29 AccNo: 0001104659-15-074155 Size: 106 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9....
$STEMLINE THERAPEUTICS INC(STML)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2015-08-11 AccNo: 0001104659-15-058734 Size: 123 KB 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ DEF 14A - Other definitive proxy statements Filed: 2015-04-30 AccNo: 0001047469-15-004225 Size: 1 MB 网页链接